Ernst Heinmöller

2PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 11, 2023
Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.

Terence M Williams, Andreas Schneeweiss, Christian Jackisch

|Apr 04, 2023
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.

Peter A Fasching, Christopher Szeto, Carsten Denkert

Pageof 1